本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aclaris Therapeutics

1.68
+0.06003.70%
盘后1.65-0.0300-1.79%18:44 EDT
成交量:34.67万
成交额:57.50万
市值:1.82亿
市盈率:-1.16
高:1.68
开:1.63
低:1.62
收:1.62
数据加载中...
2024/02/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/18

重要事件披露

Form 8-K - Current report
2023/09/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

重要事件披露

Form 8-K - Current report
2023/06/02

重要事件披露

Form 8-K - Current report